Tianshui Zhongxing Bio-technology Co.,Ltd.

Simbol: 002772.SZ

SHZ

7.08

CNY

Tržna cena danes

  • -764.5012

    Razmerje P/E

  • 44.3411

    Razmerje PEG

  • 2.78B

    Kapaciteta MRK

  • 0.00%

    Donos DIV

Tianshui Zhongxing Bio-technology Co.,Ltd. (002772-SZ) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja Tianshui Zhongxing Bio-technology Co.,Ltd., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011

balance-sheet.row.cash-and-short-term-investments

01323.51695.71858.6
1903.5
1642.2
474.6
1167.1
348.7
188.8
270
151.5
87.2
55.7

balance-sheet.row.short-term-investments

0285369.5263.4
688.6
666.3
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

028.380.921.6
53.7
47.6
34.6
27
23.2
12.3
15.9
21.8
12.4
9.3

balance-sheet.row.inventory

01274.61255.51173.9
260.8
136.1
116.9
85.9
73.5
49
41.7
32.5
23.2
14.4

balance-sheet.row.other-current-assets

032.84.824.4
-2.7
-5.8
746
671
1124.3
281.3
4.3
3.3
2.6
-1.8

balance-sheet.row.total-current-assets

02659.23036.93078.5
2215.3
1820.2
1372
1951
1569.7
531.4
331.9
209.1
125.5
77.6

balance-sheet.row.property-plant-equipment-net

02946.830743005.4
2882
2705.1
2309
1796.9
1380.5
977.6
606.3
462.7
315.6
183.3

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0334.4342.4350.6
339.1
329.6
292
233.8
216
165.7
121.8
119.5
96.1
21.7

balance-sheet.row.goodwill-and-intangible-assets

0334.4342.4350.6
339.1
329.6
292
233.8
216
165.7
121.8
119.5
96.1
21.7

balance-sheet.row.long-term-investments

0123.7-285.2-170.9
-581.8
-549
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

000268.3
688.6
666.3
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

09.7401.119.3
38.8
40.7
136.4
109.9
48.3
8.1
1.2
6.5
22.5
12.7

balance-sheet.row.total-non-current-assets

03414.63532.33472.8
3366.6
3192.8
2737.4
2140.6
1644.9
1151.4
729.3
588.7
434.2
217.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

06073.86569.16551.3
5581.9
5012.9
4109.4
4091.5
3214.6
1682.7
1061.1
797.8
559.7
295.2

balance-sheet.row.account-payables

0179.1205.4155.6
132.5
161.6
160.8
124.3
113.1
79.5
29.6
18.4
11.7
5

balance-sheet.row.short-term-debt

01009.7980.4422.6
592.2
149.1
95.4
48.7
21.5
54.3
63.8
21.8
30
18

balance-sheet.row.tax-payables

0110.7
0.7
0.7
2.1
3.9
0.8
0.9
0.5
0.6
0.6
0

balance-sheet.row.long-term-debt-total

01074.51622.52330.7
1854.6
1864.2
1029.3
1051.6
462.9
298.2
386.2
292.1
126.1
48.1

Deferred Revenue Non Current

0102.9118.5127.2
141.4
142.3
120.7
97
97.5
69.7
57
40.5
28
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0266.7252.2234.8
126.4
2
68.5
2
2.2
1.9
2.1
0.4
0.2
0.1

balance-sheet.row.total-non-current-liabilities

01074.717412480.6
1996
2006.6
1150
1148.7
560.4
367.9
443.2
332.6
154
62.3

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

00.30.30.3
0.3
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

02535.33184.53300.2
2849.7
2410.8
1476.9
1456.8
922.1
644.8
563.1
390.6
208.4
113.7

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0393.2407.5407.4
367.7
367.7
373.3
373.3
373.3
148.9
111.7
111.7
111.7
15.7

balance-sheet.row.retained-earnings

0958.9931.5819.4
803.6
653.4
622.8
549.8
447.6
309.3
208.3
120.8
68.6
34

balance-sheet.row.accumulated-other-comprehensive-income-loss

06026.127.3
42.4
227.1
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

02020.32016.61994.5
1515.4
1351.2
1634.3
1701.6
1462.1
573
175.7
172.4
169.7
131.8

balance-sheet.row.total-stockholders-equity

03432.53381.63248.6
2729.1
2599.5
2630.5
2624.7
2283
1031.3
495.7
404.8
350
181.5

balance-sheet.row.total-liabilities-and-stockholders-equity

06073.86569.16551.3
5581.9
5012.9
4109.4
4091.5
3214.6
1682.7
1061.1
797.8
559.7
295.2

balance-sheet.row.minority-interest

033.12.5
3.2
2.6
2
10
9.5
6.7
2.4
2.4
1.2
0

balance-sheet.row.total-equity

03435.53384.73251.1
2732.3
2602.1
2632.5
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-

Total Investments

0408.784.392.5
106.8
117.4
46.7
50.7
6.4
6.5
0
0
0
1.1

balance-sheet.row.total-debt

02084.42602.92753.3
2446.7
2013.3
1124.7
1100.3
484.4
352.5
450
313.9
156.1
66.1

balance-sheet.row.net-debt

01045.91276.71158.1
1231.8
1037.4
650.1
-66.7
135.7
163.8
180.1
162.4
68.8
10.4

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Tianshui Zhongxing Bio-technology Co.,Ltd. opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011

cash-flows.row.net-income

0159.6158.954.3
189.5
69
112.7
142.8
161.3
115
90.8
54.7
64
43.6

cash-flows.row.depreciation-and-amortization

0268.9275.4257.5
224.1
190.9
143.3
91.5
67.6
54.7
43.2
35
21.3
0

cash-flows.row.deferred-income-tax

00-10.9-28
-11.8
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0010.928
11.8
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-11.7-77.9-788.6
-102.9
4
-15.7
2.4
12.1
23.9
25.9
-0.4
3.3
0

cash-flows.row.account-receivables

020.7-35.72.5
53.7
-15.3
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-26.3-85.4-912.1
-125.6
-19.3
-30.1
-12.9
-24.5
-7.7
-9.2
-9.3
-8.8
0

cash-flows.row.account-payables

0-6.143.2121
-31
38.6
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0000
0
0
14.3
15.4
36.6
31.7
35.1
8.9
12.1
0

cash-flows.row.other-non-cash-items

0107.8137.363.1
78.6
95.3
-8.5
-29.3
-7.6
15.8
10.4
3.8
6
-43.6

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-107-245.9-286.5
-379.7
-663.6
-651.7
-502.1
-479.6
-185.7
-191.2
-171.7
-233
-126.5

cash-flows.row.acquisitions-net

0030.4
2424
0
0
0
0
-40.8
0
0
0
126.5

cash-flows.row.purchases-of-investments

0-400-1310-510
-2424
-2129.1
0
-20
0
0
0
0
0
-1

cash-flows.row.sales-maturities-of-investments

04501172.5959.4
22.5
20.7
38.5
37.2
13.8
2.7
0
0
1.1
0

cash-flows.row.other-investing-activites

0000.7
-22.3
2197.5
-105.2
408.5
-882.9
-281
0
0
0
-126.5

cash-flows.row.net-cash-used-for-investing-activites

0-57-380.4164.1
-379.6
-574.5
-718.4
-76.5
-1348.7
-504.8
-191.2
-171.7
-231.9
-127.5

cash-flows.row.debt-repayment

0-544.4-1520.6-680.8
-285.1
-228.3
-85.9
-91.2
-346.2
-216.9
-22.9
-62
-96
-28.1

cash-flows.row.common-stock-issued

0000
37
64
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
-37
-64
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-117.9-170.3-148.7
-103.8
-78
-49.8
-54.7
-31.4
-35.6
-25.3
-16.3
-23.4
-23.8

cash-flows.row.other-financing-activites

0-92.913231459.6
635.2
1004.8
-83.7
833.4
1654.6
496.6
159
221.3
288.3
127.8

cash-flows.row.net-cash-used-provided-by-financing-activities

0-755.2-367.9630.1
246.3
698.5
-219.4
687.5
1277
244.2
110.9
143
168.9
76

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0.1
-2.1
-1.1
0
0
0

cash-flows.row.net-change-in-cash

0-287.7-254.6380.6
256
483.1
-706
818.4
161.7
-53.3
88.9
64.3
31.6
41.6

cash-flows.row.cash-at-end-of-period

01038.51326.21580.8
1200.2
944.2
461.1
1167.1
348.7
187
240.4
151.5
87.2
55.7

cash-flows.row.cash-at-beginning-of-period

01326.21580.81200.2
944.2
461.1
1167.1
348.7
187
240.4
151.5
87.2
55.7
14.1

cash-flows.row.operating-cash-flow

0524.5493.7-413.7
389.3
359.1
231.8
207.3
233.4
209.4
170.3
93
94.6
0

cash-flows.row.capital-expenditure

0-107-245.9-286.5
-379.7
-663.6
-651.7
-502.1
-479.6
-185.7
-191.2
-171.7
-233
-126.5

cash-flows.row.free-cash-flow

0417.5247.8-700.2
9.6
-304.5
-419.9
-294.8
-246.3
23.8
-20.9
-78.7
-138.5
-126.5

Vrstica izkaza poslovnega izida

Prihodki Tianshui Zhongxing Bio-technology Co.,Ltd. so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja 002772.SZ znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011

income-statement-row.row.total-revenue

01928.11970.31556.1
1483.2
1155.8
926.4
739.8
585
479.5
383.5
263.9
190.4
131.3

income-statement-row.row.cost-of-revenue

01500.61468.81268.2
1073.9
879.5
668.5
505.9
356.1
282.1
237.8
172.7
99.7
55.4

income-statement-row.row.gross-profit

0427.5501.5288
409.3
276.3
258
233.9
228.9
197.5
145.7
91.2
90.7
75.9

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

00.633.74.5
31
24.8
-1.2
4.1
8.3
10.6
6.6
3.7
3.6
2.6

income-statement-row.row.operating-expenses

0247.2231187.4
185.1
145.8
168.1
134.2
94
84.6
55
38.6
28.7
29.9

income-statement-row.row.cost-and-expenses

01747.71699.81455.6
1259
1025.3
836.6
640.1
450.1
366.7
292.8
211.3
128.4
85.3

income-statement-row.row.interest-income

031.63153.6
43
33.6
15.7
8.1
9.2
7.5
4
2.1
0.9
0

income-statement-row.row.interest-expense

083.690.580.9
85.5
74.9
21.8
2.6
4.8
15.1
9.7
3.5
2.5
5

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-17.6-148.7-67.3
-82.1
-97.4
22.9
43.1
26.4
2.2
0.1
2.1
2
-2.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

00.633.74.5
31
24.8
-1.2
4.1
8.3
10.6
6.6
3.7
3.6
2.6

income-statement-row.row.total-operating-expenses

0-17.6-148.7-67.3
-82.1
-97.4
22.9
43.1
26.4
2.2
0.1
2.1
2
-2.5

income-statement-row.row.interest-expense

083.690.580.9
85.5
74.9
21.8
2.6
4.8
15.1
9.7
3.5
2.5
5

income-statement-row.row.depreciation-and-amortization

0268.9275.4257.5
224.1
190.9
143.3
91.5
67.6
54.7
43.2
35
21.3
5.2

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0180.4307.6121.6
271.6
166.5
113.9
138.7
153.5
104.4
84.2
51
60.4
40.9

income-statement-row.row.income-before-tax

0162.8158.954.3
189.5
69
112.7
142.8
161.3
115
90.8
54.7
64
43.6

income-statement-row.row.income-tax-expense

03.2066.7
82.7
98.1
44.6
47.7
34.6
18.4
9.4
5.9
4.5
-5.1

income-statement-row.row.net-income

0159.6158.4-12.4
106.8
-29
111.9
142.3
158.5
114.4
90.9
54.8
64
43.6

Pogosto zastavljeno vprašanje

Kaj je Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) skupna sredstva?

Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) skupna sredstva so 6073765300.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.149.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je 0.517.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -0.002.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so 0.001.

Kaj je Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je 159581340.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 2084417918.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 247154405.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 0.000.